BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| bifidobacterium longum {B.Longum } - unclassified Roseburia |
👶
Gender-based effect of absence of gut microbiota on the protective efficacy of Bifidobacterium longum-fermented rice bran diet against inflammation-associated colon tumorigenesis. Molecular carcinogenesis (Mol Carcinog ) Vol: 61 Issue 10 Pages: 941-957 Pub: 2022 Oct Epub: 2022 Jul 20 Authors Kumar R , Maurya AK , Parker KD , Kant R , Ibrahim H , Kabir MI , Kumar D , Weber AM , Agarwal R , Kuhn KA , Ryan EP , Raina K , Html Article Publication |
| bifidobacterium longum {B.Longum } - unclassified Roseburia |
👶
Bifidobacterium longum-fermented rice bran and rice bran supplementation affects the gut microbiome and metabolome. Beneficial microbes (Benef Microbes ) Vol: 10 Issue 8 Pages: 823-839 Pub: 2019 Dec 9 Epub: 2019 Sep 29 Authors Nealon NJ , Parker KD , Lahaie P , Ibrahim H , Maurya AK , Raina K , Ryan EP , Html Article Publication |
| bifidobacterium longum {B.Longum } - unclassified Roseburia |
👶
Bifidobacterium longum subsp. longum Remodeled Roseburia and Phosphatidylserine Levels and Ameliorated Intestinal Disorders and liver Metabolic Abnormalities Induced by High-Fat Diet. Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 68 Issue 16 Pages: 4632-4640 Pub: 2020 Apr 22 Epub: 2020 Apr 10 Authors Wu T , Sun M , Liu R , Sui W , Zhang J , Yin J , Fang S , Zhu J , Zhang M , Publication |
| bifidobacterium longum {B.Longum } - unclassified Roseburia |
👶
Bifidobacterium longum K5 Prevents Enterohaemorrhagic Escherichia coli O157:H7 Infection in Mice through the Modulation of the Gut Microbiota. Nutrients (Nutrients ) Vol: 16 Issue 8 Pages: Pub: 2024 Apr 13 Epub: 2024 Apr 13 Authors Liu D , Li C , Cao T , Lv X , Yue Y , Li S , Cheng Y , Liu F , Huo G , Li B , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
